Human Growth Hormone Market Opportunity And Industry Expansion Strategies 2026
In this report, the production of Human Growth Hormone increased from 170.67 Million IU in 2012 to 209 Million IU in 2016 with an average growth rate of 5.20%.
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
Download Free Sample Report @ https://www.radiantinsights.com/research/global-human-growth-hormone-market-2020-2026/request-sample
The downstream industries of Human Growth Hormone products are kids and adults. In the recent years, with the recovery of global economic, the development of emerging countries and the rising health concern, the consumption increase of Human Growth Hormone will be obvious.
For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.
North America occupied about 42.7% of the production market in 2016. It was followed by Europe and China, which respectively have around 27% and 17% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.6% of the global consumption volume in 2015.
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
• Novo Nordisk
• Pfizer
• Eli Lilly
• Merck Serono
• F.Hoffmann-LaRoche
• Ferring Pharmaceuticals
• GeneScience Pharmaceuticals
• Ipsen
• LG Life Sciences
• Sandoz International
• Anhui Anke Biotechnology
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
• Powder
• Solvent
By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
• Growth Hormone Deficiency (GHD)
• Turner Syndrome
• Chronic Renal Insufficiency
• Prader Willi Syndrome
• Small for Gestational Age
• SHOX Deficiency
• Others
By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
• China
• USA
• Europe
• Japan
• Korea
• India
• Southeast Asia
• South America
Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/global-human-growth-hormone-market-2020-2026
Table of Contents
Global Human Growth Hormone Market Professional Survey Report 2019
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 Powder
1.3.2 Solvent
1.4 Application Overview
1.4.1 Growth Hormone Deficiency (GHD)
1.4.2 Turner Syndrome
1.4.3 Chronic Renal Insufficiency
1.4.4 Prader Willi Syndrome
1.4.5 Small for Gestational Age
1.4.6 SHOX Deficiency
1.4.7 Others
1.5 Industrial Chain
1.5.1 Human Growth Hormone Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 Powder
2.1.2 Solvent
2.2 The Overall Market Performance(Value)
2.2.1 Powder
2.2.2 Solvent
3 Global Human Growth Hormone Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 Growth Hormone Deficiency (GHD)
3.3 Turner Syndrome
3.4 Chronic Renal Insufficiency
3.5 Prader Willi Syndrome
3.6 Small for Gestational Age
3.7 SHOX Deficiency
3.8 Others
Continued…
Read all Reports of this category @ https://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: [email protected]
Website: https://www.radiantinsights.com/